ArticleBMJ public health2026
Beyond campaigns: a national mixed-methods study on advancing routine HPV vaccination in Lesotho.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lesotho has historically delivered human papillomavirus (HPV) vaccination through school-based campaigns, achieving high uptake of the first dose but lower completion of subsequent doses. This study assessed HPV vaccination coverage, dropout rates, documentation practices and the behavioural and social drivers (BeSD) of uptake to inform the transition towards routine HPV vaccination. Methods: A nationally representative mixed-methods survey was conducted in 2024. The quantitative component involved visits to 5111 households and identifying 279 eligible girls aged 9-17 years. Data were collected on receipt of HPV dose 1 and dose 2, availability of vaccination cards and caregiver knowledge. Additionally, 15 key informant interviews were conducted with adolescent girls, caregivers and service providers in Butha-Buthe and Quthing to explore barriers to communication, trust and access. Weighted survey estimates and logistic regression were used for quantitative analysis, while qualitative data were analysed thematically using the WHO BeSD framework. Results: HPV dose 1 coverage was 85%, while dose 2 coverage was 52.9%, reflecting a 32% dropout rate. In-school girls had higher completion rates than out-of-school girls. Caregiver education and trust in health workers were strong predictors of vaccine uptake. Only 43% of vaccinated girls were able to present a vaccination card. Qualitative findings highlighted communication gaps in follow-up doses, limited access for out-of-school girls due to school-based delivery, and the significant role of trust in health workers as a key factor influencing vaccine acceptance. Conclusion: High uptake of HPV dose 1 demonstrates strong acceptance; however, substantial dropout and inequities persist, particularly among out-of-school girls. Strengthened communication, improved documentation and expanded delivery strategies are needed. Integrating HPV vaccination into routine primary healthcare and adopting the WHO-recommended single-dose schedule could enhance equitable coverage and support cervical cancer elimination efforts in Lesotho.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.